Influences of CYP2D6*10 polymorphisms on the pharmacokinetics of iloperidone and its metabolites in Chinese patients with schizophrenia: a population pharmacokinetic analysis

被引：0
|
作者：
Qi Pei
Lu Huang
Jie Huang
Jing-kai Gu
Yun Kuang
Xiao-cong Zuo
Jun-jie Ding
Hong-yi Tan
Cheng-xian Guo
Shi-kun Liu
Guo-ping Yang
机构：
[1] Third Xiangya Hospital,Center of Clinical Pharmacology and Pharmacy Department
[2] Central South University,undefined
[3] Drug Metabolism Research Center of Jilin University,undefined
[4] Children's Hospital of Fudan University,undefined
来源：
Acta Pharmacologica Sinica | 2016年 / 37卷
关键词：
schizophrenia; iloperidone; gene polymorphisms; 10; population pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1499 / 1508
页数：9
相关论文
共 50 条
  • [1] Influences of CYP2D6*10 polymorphisms on the pharmacokinetics of iloperidone and its metabolites in Chinese patients with schizophrenia: a population pharmacokinetic analysis
    Pei, Qi
    Huang, Lu
    Huang, Jie
    Gu, Jing-kai
    Kuang, Yun
    Zuo, Xiao-cong
    Ding, Jun-jie
    Tan, Hong-yi
    Guo, Cheng-xian
    Liu, Shi-kun
    Yang, Guo-ping
    ACTA PHARMACOLOGICA SINICA, 2016, 37 (11) : 1499 - 1508
  • [2] The impact of CYP2D6 polymorphisms on the pharmacokinetics of codeine and its metabolites in Mongolian Chinese subjects
    Xiujun Wu
    Li Yuan
    Jinliang Zuo
    Jing Lv
    Tao Guo
    European Journal of Clinical Pharmacology, 2014, 70 : 57 - 63
  • [3] The impact of CYP2D6 polymorphisms on the pharmacokinetics of codeine and its metabolites in Mongolian Chinese subjects
    Wu, Xiujun
    Yuan, Li
    Zuo, Jinliang
    Lv, Jing
    Guo, Tao
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (01) : 57 - 63
  • [4] EFFECTS OF CYP2D6*10/*10 GENOTYPE ON THE PHARMACOKINETICS OF ATOMOXETINE AND ITS METABOLITES
    Park, J., I
    Choi, C., I
    Bae, J. W.
    Jang, C. G.
    Lee, S. Y.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 65 - 65
  • [5] Effects of the CYP2D6*10 allele on the pharmacokinetics of atomoxetine and its metabolites
    Byeon, Ji-Yeong
    Kim, Young-Hoon
    Na, Han-Sung
    Jang, Jong-Hwa
    Kim, Se-Hyung
    Lee, Yun-Jeong
    Bae, Jung-Woo
    Kim, In Su
    Jang, Choon-Gon
    Chung, Myeon-Woo
    Lee, Seok-Yong
    ARCHIVES OF PHARMACAL RESEARCH, 2015, 38 (11) : 2083 - 2091
  • [6] Effects of the CYP2D6*10 allele on the pharmacokinetics of atomoxetine and its metabolites
    Ji-Yeong Byeon
    Young-Hoon Kim
    Han-Sung Na
    Jong-Hwa Jang
    Se-Hyung Kim
    Yun-Jeong Lee
    Jung-Woo Bae
    In Su Kim
    Choon-Gon Jang
    Myeon-Woo Chung
    Seok-Yong Lee
    Archives of Pharmacal Research, 2015, 38 : 2083 - 2091
  • [7] Effect of CYP2D6 polymorphisms on the pharmacokinetics of propafenone and its two main metabolites
    Rouini, Mohammad-Reza
    Afshar, Minoo
    THERAPIE, 2017, 72 (03): : 373 - 382
  • [8] Effect of the CYP2D6*10 allele on the pharmacokinetics of clomiphene and its active metabolites
    Kim, Mi-Jung
    Byeon, Ji-Yeong
    Kim, Young-Hoon
    Kim, Se-Hyung
    Lee, Choong-Min
    Jung, Eui Hyun
    Chae, Won Ki
    Lee, Yun Jeong
    Jang, Choon-Gon
    Lee, Seok-Yong
    Choi, Chang-Ik
    ARCHIVES OF PHARMACAL RESEARCH, 2018, 41 (03) : 347 - 353
  • [9] Effect of the CYP2D6*10 allele on the pharmacokinetics of clomiphene and its active metabolites
    Mi-Jung Kim
    Ji-Yeong Byeon
    Young-Hoon Kim
    Se-Hyung Kim
    Choong-Min Lee
    Eui Hyun Jung
    Won Ki Chae
    Yun Jeong Lee
    Choon-Gon Jang
    Seok-Yong Lee
    Chang-Ik Choi
    Archives of Pharmacal Research, 2018, 41 : 347 - 353
  • [10] Impact of CYP2D6 polymorphisms on the pharmacokinetics of lovastatin in Chinese subjects
    Ophelia Qi Ping Yin
    Valiant Wah Lun Mak
    Miao Hu
    Benny Siu Pong Fok
    Moses Sing Sum Chow
    Brian Tomlinson
    European Journal of Clinical Pharmacology, 2012, 68 : 943 - 949
12345